Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subclinical encephalopathy

A T Blei1, J Cordoba

  • 1Department of Medicine, Lakeside VA Medical Center, Chicago, Ill 60611, USA.

Digestive Diseases (Basel, Switzerland)
|January 1, 1996
PubMed
Summary

Subclinical hepatic encephalopathy (SHE) involves cognitive deficits in cirrhosis patients, diagnosed via psychometric tests. While its impact on daily life and treatment benefits are debated, some antiencephalopathic drugs may help.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.

European journal of internal medicine·2023
Same author

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same author

In Vitro Activities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii.

Antimicrobial agents and chemotherapy·2015
Same author

Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation.

AJNR. American journal of neuroradiology·2011
Same author

Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality.

Respiratory medicine·2011
Same author

Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

Alimentary pharmacology & therapeutics·2011

Area of Science:

  • Hepatology
  • Neurology
  • Neuropsychology

Background:

  • Subclinical hepatic encephalopathy (SHE) is common in cirrhosis patients.
  • Diagnosis currently relies on psychometric testing due to lack of biomarkers.
  • Attentional and motor deficits are primary neurocognitive impairments.

Purpose of the Study:

  • To review the characteristics and diagnostic challenges of SHE.
  • To discuss the impact of SHE on daily activities and driving.
  • To evaluate the current evidence for SHE treatment.

Main Methods:

  • Literature review of studies on SHE in cirrhosis.
  • Analysis of psychometric test data for SHE diagnosis.
  • Evaluation of clinical impact and treatment efficacy.

Main Results:

  • SHE is characterized by attentional and motor deficits.
  • The impact on daily activities, like driving, is debated.
  • Treatment benefits are not definitively established, but some drugs show promise.

Conclusions:

  • SHE diagnosis requires psychometric evaluation.
  • Further research is needed to clarify SHE's impact and optimal treatment.
  • Antiencephalopathic drugs may be considered for select patients.

Related Experiment Videos